OncoResponse, Inc
Biotechnology company · Houston, Texas, United States
OncoResponse, Inc is a biotechnology company headquartered in Houston, Texas, United States. Its earliest recorded incorporation is in 2015. It has reported private securities offerings to the US SEC, most recently $6 million sold in a notice filed in 2025.
OncoResponse at a glance
What does OncoResponse do?
Private fundraising reported to the SEC
7 Form D notices; the most recent reported $6 million sold (2025).
Frequently asked questions about OncoResponse
Where is OncoResponse headquartered?
OncoResponse, Inc is headquartered in Houston, Texas, United States.
What does OncoResponse do?
OncoResponse, Inc is a biotechnology company.
When was OncoResponse founded?
The earliest incorporation on record for OncoResponse, Inc is in 2015, according to public company registers.
Similar companies
- Pulmotect, Inc.Houston, Texas, United States
- Kiromic Biopharma, Inc.Houston, Texas, United States
- March Biosciences, Inc.Houston, Texas, United States
- Autoimmunity Biologic Solutions Inc.Houston, Texas, United States
- Fannin Partners, LLCHouston, Texas, United States
- Brevitest Technologies, Inc.Houston, Texas, United States
- Pupil Bio, Inc.Houston, Texas, United States
- Asylia Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences